BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19483281)

  • 21. A unique case of adult hypophosphatemic osteomalacia.
    Edelson GW; Shih MS; Parfitt AM
    Bone; 1993; 14(5):707-10. PubMed ID: 8268043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital Conditions of Hypophosphatemia in Children.
    Imel EA
    Calcif Tissue Int; 2021 Jan; 108(1):74-90. PubMed ID: 32328695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia].
    Kinoshita Y; Fukumoto S
    Clin Calcium; 2014 Aug; 24(8):1217-22. PubMed ID: 25065874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor-induced hypophosphatemic osteomalacia].
    Ito N; Fukukmoto S
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets.
    Reusz GS
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):147-51. PubMed ID: 8578931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.
    Saito T; Nishii Y; Yasuda T; Ito N; Suzuki H; Igarashi T; Fukumoto S; Fujita T
    Eur J Endocrinol; 2009 Oct; 161(4):647-51. PubMed ID: 19581284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.
    Ovejero D; Lim YH; Boyce AM; Gafni RI; McCarthy E; Nguyen TA; Eichenfield LF; DeKlotz CM; Guthrie LC; Tosi LL; Thornton PS; Choate KA; Collins MT
    Osteoporos Int; 2016 Dec; 27(12):3615-3626. PubMed ID: 27497815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption.
    Johnson K; Levine K; Sergi J; Chamoun J; Roach R; Vekich J; Favis M; Horn M; Cao X; Miller B; Snyder W; Aivazian D; Reagan W; Berryman E; Colangelo J; Markiewicz V; Bagi CM; Brown TP; Coyle A; Mohammadi M; Magram J
    J Bone Miner Res; 2017 Oct; 32(10):2062-2073. PubMed ID: 28600887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
    Michigami T
    Clin Calcium; 2009 Jun; 19(6):785-92. PubMed ID: 19483272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia.
    Högler W; Kapelari K
    J Bone Miner Res; 2020 Feb; 35(2):226-230. PubMed ID: 31834957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family].
    Negri AL; Negrotti T; Alonso G; Pasqualini T
    Medicina (B Aires); 2004; 64(2):103-6. PubMed ID: 15628294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
    Garabedian M
    Curr Opin Pediatr; 2007 Aug; 19(4):488-91. PubMed ID: 17630616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak.
    Rendina D; Mossetti G; De Filippo G; Cioffi M; Strazzullo P
    J Clin Endocrinol Metab; 2006 Mar; 91(3):959-63. PubMed ID: 16352682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adult-onset sex-linked familial hypophosphatemic osteomalacia].
    Radó J; Haris A; Szebenyi B
    Orv Hetil; 1997 Jun; 138(26):1683-8. PubMed ID: 9289682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypophosphatemia: A Practical Guide to Evaluation and Management.
    Tebben PJ
    Endocr Pract; 2022 Oct; 28(10):1091-1099. PubMed ID: 35940468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.